1.Study of pathogenicity of bacterial L-forms
Houdong LÜ ; Ronghua LI ; Mingguo TIAN ; Hui CAO ; Meiying YI
Chinese Medical Journal 1998;111(3):0-0
Objective To find out the pathogenicity of bacterial L-forms.Methods β-glucuronidase activities of both E.coli and their L-forms were determined with modified Fishman's method. The endotoxin content in 3 kinds of Gram negtive bacteria and their L-forms were measured with the limulus lysate test. Under ultrasonography, percutaneous transhepatic cholecystic punctures were performed on 2 groups of 10 healthy dogs. E.coli and their L-forms were respectively injected into the gallbladders of the 2 groups. 48 hours later, the gallbladder bile was obtained through puncture and cultured. After 6 months, all the animals were killed. Their bile was cultured and the gallbladders were pathologically analysed.Results Endotoxin existed in L-forms of Gram negtive bacteria (about 1/3-1/2 of the original forms). L-forms of E.coli also produced β-glucuronidase (58.67% activity of the original forms). A half of the E.coli which had stayed in the canine gallbladders for 48 hours have been transformed into L-forms by the action of bile and other factors. The L-forms existed in the gallbladder bile longer than 6 months. The gallbladders showed chronic infections: mild atrophy of mucosa, white blood cell and lymph cell infiltration in submucosa and slight fiberosis of the gallbladder walls. Bacterial L-forms were found in mucosa cells.Conclusions Bacterial L-forms can also produce pathogenical materials, but the amount is less than that of the original bacterial forms. Both bacterial forms and L-forms can lead to chronic infection of the canine gallbladders.
2.Interaction of anti-thrombotic and anti-inflammatory activities of commonly used traditional Chinese medicine for promoting blood circulation and removing blood stasis revealed by network pharmacology analysis.
Ming LÜ ; Tai-yi WANG ; Xiao-xuan TIAN ; Xin-hui SHI ; Guan-wei FAN ; Yan ZHANG ; Yan ZHU
Acta Pharmaceutica Sinica 2015;50(9):1135-1141
Chinese traditional patent medicine for promoting blood circulation and removing blood stasis(PBCRBS) originated from traditional Chinese medicine theory and had approved efficacy and safety standards. However, its compatibility regularity and anti-thrombotic mechanism is not clear. To analyze the compatibility regularity and anti-thrombotic mechanism of Chinese traditional patent medicine for PBCRBS, a statistical and bioinformatics analysis was carried out using traditional Chinese medicine inheritance support system (TICMISS, V2.0) and ingenuity pathway analysis (IPA). The compatibility regularity analysis shows that the most commonly used herb combinations are Danshen (Salvia miltiorrhiza Bge.), Chuanxiong (Ligusticum chuanxiong Hort.) and Honghua (Carthamustinctorius L.). The anti-thrombotic mechanism analysis reveals that 25 ingredients have an effect on 29 thrombosis related molecules which 23 molecules are related to inflammation response. Furthermore, there are 5 inflammation molecules (NOS2, PTGS2, IL6, TNF, IL1β) served as major targets. At the same time, Danshen, Chuangxiong and Honghua mainly used as sovereign herb or minister herb in the application of cardiovascular and cerebrovascular diseases. Therefore, Chinese traditional patent medicine for PBCRBS probably has an effect on anti-thrombotic activity through inhibiting the inflammatory response. In summary, the most commonly used herb combinations of Chinese traditional patent medicine for PBCRBS are Danshen, Chuanxiong and Honghua. Inhibiting inflammatory response, especially inflammation related molecules (NOS2, PTGS2, IL6, TNF and IL1β), is probably a new starting point to clarify the anti-thrombotic mechanism of Chinese patent medicine for PBCRBS.
Anti-Inflammatory Agents
;
pharmacology
;
Carthamus tinctorius
;
Computational Biology
;
Drugs, Chinese Herbal
;
pharmacology
;
Fibrinolytic Agents
;
pharmacology
;
Humans
;
Inflammation
;
drug therapy
;
Medicine, Chinese Traditional
3.Alpha-blockers and bioflavonoids in men with chronic nonbacterial prostatitis (NIH-IIIa): a prospective, placebo-controlled trial.
Ming LÜ ; Sheng-tian ZHAO ; Shu-mei WANG ; Ben-kang SHI ; Yi-dong FAN ; Jie-zhen WANG
Chinese Journal of Epidemiology 2004;25(2):169-172
OBJECTIVEThe National Institutes of Health (NIH) category IIIa chronic prostatitis syndromes (non bacterial chronic prostatitis) were common disorders but with few effective therapies. Alpha-blockers and bioflavonoids had recently been reported in randomized controlled trials to improve the symptom of these disorders in a significant proportion of men. The aim of this study was to confirm these findings in a prospective randomized, placebo-controlled trial.
METHODSForty-five men with category IIIa chronic non bacterial protatitis were randomized into three groups as follows: (1) placebo; (2) phenoxybenzamine-hydrochloride:10 mg two times a day for one month; (3) flavoxate HCI-neptumus: 200 mg three times a day for one month. The NIH chronic prostatitis symptom score was used to grade symptoms at the beginning and conclusion of the study.
RESULTSAll the patients in three groups completed the study except three dropout patients in placebo group because of sever symptoms. The three groups were similar in age, duration of symptoms and initial symptom score. Patients taking placebo had a mean improvement in NIH-CPSI from 21.85 to 19.55 (not significant), while the phenoxybenzamine-hydrochloride group had a mean improvement from 21.95 to 13.75 (P < 0.01), and those taking flavoxate HCI-neptumus had a mean improvement from 21.75 to 16.95 (P < 0.05). The decrease in NIH-CPSI was associated with significant improvement in patients' clinical manifestations.
CONCLUSIONTherapy with alpha-blockers was well tolerated with significant symptomatic improvement in most men having chronic non-bacterial chronic protatitis while the bioflavonoids group had no significant improvement. Mechanism of both medicines needs further study.
Adrenergic alpha-Antagonists ; administration & dosage ; therapeutic use ; Adult ; Chronic Disease ; Flavonoids ; administration & dosage ; therapeutic use ; Flavoxate ; therapeutic use ; Humans ; Male ; Parasympatholytics ; therapeutic use ; Prospective Studies ; Prostatitis ; drug therapy ; Treatment Outcome
4.Humoral immune response and in vitro neutralizing antibody assay on co-delivery of protein HPV16L1 virus-like particle with HPV16L1 gene.
Jian-ming SONG ; Xiang-le SUN ; Yi-li WANG ; Jian-fen GUO ; Tian-ju LIU ; Lü-sheng SI
Chinese Journal of Pathology 2005;34(7):421-424
OBJECTIVETo compare humoral immune response by co-inoculating mice with antigen HPV16L1 virus-like particle (VLP) and HPV16L1 recombinant plasmids and then observing the neutralizing antibody activity in vitro.
METHODSC57BL/6 mice were injected intramuscularly/subcutaneously with pcDNA-L1 plasmids plus HPV16L1 VLP. Serum IgG levels were detected by ELISA, antibody neutralizing protective activities were determined by hemagglutination inhibition and HPV16L1 VLP binding inhibition assay.
RESULTSSerum antibody titers and neutralizing antibody activities were increased in HPV16L1 plasmids plus HPV16L1 VLP proteins in co-immunized mice when compared with controls.
CONCLUSIONCo-inoculation of the HPV16L1 VLP protein can enhance production of neutralizing antibody activities against aimed antigen, which should be a more promising strategy for effective HPV16 prophylactic vaccine development.
Animals ; Antibodies, Viral ; blood ; Capsid Proteins ; genetics ; immunology ; Erythrocyte Aggregation ; Genes, Viral ; HeLa Cells ; Human papillomavirus 16 ; genetics ; immunology ; Humans ; Immunization ; Immunoglobulin G ; blood ; Mice ; Mice, Inbred C57BL ; Neutralization Tests ; Oncogene Proteins, Viral ; genetics ; immunology ; Plasmids ; Recombinant Proteins ; immunology
5.Sexual differences in hepatic ischemic reperfusion injury in rats are related to endothelial cell nitric oxide synthase-derived nitric oxide.
Ping LÜ ; Fang LIU ; Zhong YAO ; Chun-you WANG ; Dao-da CHEN ; Yuan TIAN ; Jin-hui ZHANG ; Yi-hua WU
Chinese Journal of Hepatology 2005;13(11):851-853
Animals
;
Female
;
Liver
;
blood supply
;
Male
;
Nitric Oxide
;
metabolism
;
Nitric Oxide Synthase Type III
;
metabolism
;
Rats
;
Rats, Wistar
;
Reperfusion Injury
;
metabolism
;
Sex Factors
6.Pathological analysis of heroin spongiform leukoencephalopathy.
Jia YIN ; Su-yue PAN ; Liang ZHOU ; Tian-min LÜ ; Yi-feng LUO ; Bing-xun LU
Journal of Southern Medical University 2007;27(6):881-883
OBJECTIVETo investigate the pathological characteristics of heroin spongiform leukoencephalopathy (HSLE).
METHODSCerebral tissue specimens were obtained from 15 patients with HSLE and the histological observations under optical and electron microscopes were carried out by HE, Bielschowsky's, and chromotrope 2R-brilliant green staining.
RESULTSHSLE was characterized primarily by spongiform vacuolar degeneration of the cerebral white matter. Neurons in the gray matter, Purkinje and granular cells in the cerebella remain intact in all the cases. Numerous vacuoles, which merged to form larger cavities, appeared in the damaged white matter, and the axons survived in the deep white matter. The myelin sheath in the cerebellar white matter sustained more severe damages than those in the cerebral white matter. No vacuoles or lymphocyte infiltration occurred in the small peripheral vessels.
CONCLUSIONHSLE is pathologically characterized by vacuolar degeneration due to primary damage of the myelin, and the spongiform vacuolar degeneration is closely associated with the severity of demyelination in the white matter.
Adult ; Autopsy ; Canavan Disease ; etiology ; pathology ; Cerebellum ; chemistry ; pathology ; ultrastructure ; Cerebral Cortex ; chemistry ; pathology ; ultrastructure ; Female ; Heroin Dependence ; complications ; Humans ; Male ; Microscopy, Electron ; Middle Aged ; Neurons ; chemistry ; pathology ; Purkinje Cells ; chemistry ; pathology ; Staining and Labeling ; methods ; Young Adult
7.A recommendable standard protocol of adult male circumcision with the Chinese Shang Ring: outcomes of 328 cases in China.
Yue CHENG ; Yi-Feng PENG ; Yi-Dong LIU ; Long TIAN ; Nian-Qing LÜ ; Xin-Jun SU ; Ze-Jun YAN ; Jia-Sheng HU ; Richard LEE ; Howard H KIM ; David C SOKAL ; Philip S LI
National Journal of Andrology 2009;15(7):584-592
OBJECTIVEStandardization of and training in adult male circumcision can significantly reduce its complication rate. Currently no such program exists for its standardization and training, making it difficult to guarantee the quality of male circumcision services. We therefore established a standardized surgical protocol for adult male circumcision in China using the Shang Ring, and applied it to a clinical study examining the performance of the Shang Ring in adult male circumcision.
METHODSA total of 328 adult men aged 18-58 (mean 27.8) years, 25 with phimosis and 303 with redundant prepuce, underwent circumcision with the Shang Ring, and evaluation of the operation time, pain scores (using the visual analog scale), postoperative complications, time for wound healing, and their satisfaction with the postoperative appearance.
RESULTSThe operation time was 4.7 +/- 1.3 minutes. The pain scores were 0. 2 +/- 0.6 during the surgery, 1.6 +/- 1.0 twenty hours postoperatively, 1.7 +/- 1.1 twenty hours prior to the ring removal, and 2.7 +/- 1.4 during the ring removal. Complications included infection in 2 (0.6%), bleeding in 2 (0.6%), and wound dehiscence in 2 (0.6%) of the patients. None of the patients with wound dehiscence required postoperative suturing and all were managed conservatively instead. Sixteen of the patients (4.9%) experienced penile edema. The time for complete wound healing after circumcision was 20.3 +/- 6.7 days. The rate of the patients'satisfaction was 99.7% (327/328).
CONCLUSIONThe standard protocol of adult male circumcision with the Shang Ring has the advantages of short operation time, slight pain, low rate of complications, and high satisfaction and acceptance of the patients. Strict standardization of the surgical protocol can maximize its clinical advantages for adult male circumcision.
Adolescent ; Adult ; China ; Circumcision, Male ; methods ; standards ; Humans ; Male ; Middle Aged ; Phimosis ; surgery ; Reference Standards ; Young Adult
8.The need for high-quality training and surgical standards for adult male circumcision in China.
Philip S LI ; Nian-Qing LÜ ; Yue CHENG ; Yi-Feng PENG ; Long TIAN ; Yi-Dong LIU ; Kun-Long BEN ; Jian-Chuns XU ; Richard LEE ; Howard KIM ; David C SOKAL
National Journal of Andrology 2009;15(5):390-394
Although HIV is a significant problem in Africa, HIV infection rates are rising rapidly in other regions such as Asia and South America. International health organizations have recognized the need to develop effective strategies to check the worldwide transmission of HIV. Studies have demonstrated the significant reduction of HIV, HPV, HSV-2 and other STD infection rates with male circumcision (MC). Although numerous MC techniques are available, there are no standardized protocols and surgical training programs. Studies have shown that the standardization of MC techniques coupled with training programs can significantly reduce complication rates. High complication rates have been a primary obstacle to the implementation of MC services. We recommend the establishment of surgical standards and training protocols prior to the promotion of MC services in China.
China
;
Circumcision, Male
;
standards
;
HIV Infections
;
prevention & control
;
Humans
;
Male
9.A randomized, multicenter controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with elcatonin in postmenopausal women with osteoporosis in China.
Xiu-Zhen ZHANG ; Bo WANG ; Jun YANG ; Miao XUAN ; Li-Ge SONG ; Hong LI ; Xiao-Hui GUO ; Xiao-Feng LÜ ; Qing-Yun XUE ; Gang-Yi YANG ; Qiu-He JI ; Jie SHEN ; Zhi-Min LIU ; Cheng-Jiang LI ; Tian-Feng WU ; Xiao-Cui TONG ; Yuan JIA
Chinese Medical Journal 2009;122(24):2933-2938
BACKGROUNDRecombinant human parathyroid hormone (1-34) (rhPTH (1-34)) given by injection is a new seventh class drug of biological products, which is prepared by adopting gene recombination technique. rhPTH (1-34) is mainly used to treat osteoporosis, especially for postmenopausal women. This study compared the clinical efficacy and safety of rhPTH (1-34) with elcatonin for treating postmenopausal women with osteoporosis in 11 urban areas of China.
METHODSTwo hundred and five women with osteoporosis were enrolled in a 6-month, multicenter, randomized, controlled study. They were randomized to receive either rhPTH (1-34) 20 microg (200 U) daily or elcatonin 20 U weekly. Lumbar spine (L1-4) and femoral neck bone mineral density (BMD), as well as biochemical markers of bone turnover were measured. Adverse events were recorded.
RESULTSrhPTH (1-34) increased lumbar BMD significantly more than did elcatonin at 3 months and 6 months (2.38% vs 0.59%, P < 0.05; 5.51% vs 1.55%, P < 0.01), but there were no significant increases of BMD in these two groups at femoral neck. There were larger mean increases in bone markers in the rhPTH (1-34) group than in the elcatonin group at 3 months and 6 months (serum bone-specific alkaline phosphatase (BSAP) 36.79% vs 0.31%; 92.42% vs -0.17%; urinary N-telopeptide/creatinine (NTX/Cr) 48.91% vs -5.32%; 68.82% vs -10.86%). Both treatments were well tolerated and there were no significant differences detected between the two groups in the proportion of any adverse events and any serious adverse events (67.0% vs 59.0%; 0 vs 0).
CONCLUSIONSrhPTH (1-34) has more positive effects on bone formation, as shown by the larger increments of lumbar BMD and bone formation markers, than elcatonin, with only mild adverse events and no significant change in the liver, kidney or hematological indices.
Aged ; Calcitonin ; analogs & derivatives ; pharmacology ; therapeutic use ; Female ; Humans ; Middle Aged ; Osteogenesis ; drug effects ; Osteoporosis, Postmenopausal ; drug therapy ; Parathyroid Hormone ; pharmacology ; therapeutic use ; Recombinant Proteins ; pharmacology ; therapeutic use
10.The prevention of hepatolithiasis and biliary stricture post choledochojejunostomy.
Yu-long YANG ; Wen-xiang TAN ; Zhong-yi FENG ; Wei-li FU ; Hong-wei GUO ; Gui-ling LANG ; Li-gang XI ; Xiao-guang WANG ; Wei MAO ; Wen-cai LÜ ; Xiao-liang WANG ; Shuo-dong WU ; Hong YU ; Zhong TIAN
Chinese Journal of Surgery 2006;44(23):1604-1606
OBJECTIVETo investigate the prevention of hepatolithiasis and biliary stricture post choledochojejunostomy using choledochoscopy technique and evaluate feasibility and efficacy of choledochojejunostomy and artificial valve of efferent loop in preventing reflux.
METHODSTo analyze the data of 47 patients with hepatolithiasis who had been operated with Roux-en-Y cholangiojejunostomy and artificial valve of efferent loop to prevent bilio-intestinal regurgitation. Of the patients, 19 were marked with silver nip at the jejunum export of bilio-intestinal anastomosis. The regurgitation, recurrence, anastomotic stricture and their managements after the surgery were investigated.
RESULTSThe bilio-intestinal regurgitation were found in 32 cases (32/47, 68.1%), it suggested that artificial valve could not prevent bilio-intestinal regurgitation efficiently. Two cases of hepatolithiasis recurred and were cured by sinus tract placement with the aid of silver nip mark under choledochoscope instead of re-operation. Of the 6 cases with anastomotic stricture, 5 cases were treated successfully with stone extraction, biliary stent dilatation under the percutaneous transhepatic cholangioscopy (PTCS) and the other one case died.
CONCLUSIONSSilver nip mark provides safe and simple path for the cholangioscopy, it made the treatment of the recurrent biliary stricture and stone safe and brief, made the cholangioscopy play more important role in the hepatolithiasis, residual stone and biliary stricture. PTCS is mini-invasive, safe, simple and effective.
Adult ; Aged ; Anastomosis, Roux-en-Y ; adverse effects ; Bile Ducts, Intrahepatic ; Cholelithiasis ; prevention & control ; surgery ; Cholestasis, Intrahepatic ; etiology ; prevention & control ; surgery ; Endoscopy, Digestive System ; methods ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Postoperative Complications ; prevention & control ; surgery ; Retrospective Studies ; Secondary Prevention ; Treatment Outcome